PolicyBrief
S. 5127
119th CongressJul 23rd 2026
Harley Jacobsen Clinical Trial Participant Income Exemption Act of 2026
IN COMMITTEE

The Harley Jacobsen Clinical Trial Participant Income Exemption Act of 2026 excludes clinical trial compensation from federal income tax and ensures these payments do not disqualify participants from receiving federal assistance.

Jim Banks
R

Jim Banks

Senator

IN

LEGISLATION

New Tax Exemption for Clinical Trial Pay: Participants to Keep 100% of Stipends Starting 2026.

The Harley Jacobsen Clinical Trial Participant Income Exemption Act of 2026 changes the math for anyone considering joining a medical research study. Starting January 1, 2026, the bill creates a new section in the tax code (Section 139M) that officially classifies clinical trial payments as tax-free. Whether you are receiving a stipend for your own time or for a dependent’s participation, that money will no longer be considered 'gross income' by the IRS. This includes both the flat compensation for the trial itself and any reimbursements for 'reasonable and necessary' expenses like travel or lodging.

Keeping the IRS Out of the Lab

Under current rules, money earned from medical research is often treated like a side hustle or a part-time job, meaning come April, you might owe a chunk of it back to the government. This bill flips that script. For example, if a software developer participates in a weekend sleep study that pays $1,500, they would currently report that as taxable income. Under Section 2 of this bill, that $1,500 stays entirely in their pocket. The legislation also broadens the scope of what counts as a 'qualified' trial by removing the requirement that a disease be 'life-threatening.' This means research for everything from chronic migraines to seasonal allergies now qualifies for the tax break.

Protecting Your Safety Net

One of the most significant shifts in this bill is found in Section 3, which acts as a shield for federal benefits. Currently, a low-income senior or a gig worker on SNAP (food stamps) might hesitate to join a clinical trial because the extra cash could push them over the income limit for their benefits. This bill explicitly states that clinical trial compensation cannot be counted as 'income or resources' when determining eligibility for any federal program or state/local program funded by federal dollars. It ensures that a one-time payment for participating in a drug trial doesn't accidentally disqualify a family from their housing assistance or healthcare coverage.

Practical Impacts and Implementation

Because the language in this bill is straightforward (Low Vagueness), the rollout is relatively clean: if the payment happens after December 31, 2025, it’s exempt. This clarity is a win for both the participants and the researchers who often struggle to recruit diverse candidates due to these exact financial hurdles. By removing the tax hit and the risk to social safety nets, the bill effectively lowers the 'cost' of being a volunteer. For a trade worker who has to take a day off work to visit a clinic, the reimbursement for their time now carries its full value, making it much easier to justify the trip without worrying about a complicated tax return or a letter from the benefits office later.